Recent advances in paediatric cardiac anaesthesia

Mahesh Vakamudi1, Harish Ravulapalli, Ranjith Karthikeyan

  • 1Department of Anesthesiology, Critical Care and Pain Medicine, Sri Ramchandra University, Porur, Chennai, Tamil Nadu, India.

Insights

Recent advances in pediatric cardiac anesthesia improve care for children with congenital heart disease. Innovations in preoperative evaluation, anesthetic management, and postoperative care enhance outcomes for this vulnerable population.

Area of Science:

  • Pediatric Cardiac Anesthesia
  • Congenital Heart Disease Management
  • Surgical Patient Care

Background:

  • Pediatric cardiac anesthesia requires specialized expertise due to unique physiology in children with complex congenital heart disease.
  • Recent advancements have significantly improved outcomes for this vulnerable patient group.

Purpose of the Study:

  • To review recent advances in anesthetic management for pediatric cardiac surgery.
  • To cover the spectrum from preoperative evaluation to postoperative care.

Main Methods:

  • Review of current literature and technological advancements in pediatric cardiac anesthesia.
  • Discussion of imaging techniques, monitoring, cardiopulmonary bypass, and pharmacologic agents.

Main Results:

  • Advances include improved preoperative assessment (MRI, MRA), ultrasound-guided vascular access, and optimized use of cuffed endotracheal tubes.
  • Technological improvements in monitoring, cardiopulmonary bypass (centrifugal pumps, ECMO, DHCA), and pharmacotherapy (alpha-2 agonists) enhance patient care.
  • Focus on fast-tracking and effective postoperative pain management contributes to better patient outcomes.

Conclusions:

  • Continuous innovation in pediatric cardiac anesthesia leads to enhanced patient care and improved outcomes.
  • Multifaceted advancements across anesthetic management, technology, and pharmacotherapy are crucial for this subspecialty.

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques01:30

Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway interventions are...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.